← All news

FROM THE NEWS FEED

Compass Pathways Launches ‘Change the Tune in TRD’ in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 2026

2026-09-15 • Psychedelic Invest

Article summary

LONDON & NEW YORK, September 15, 2026--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today announced…

Continue to the original publication for the complete article.